ArticleArchives of orthopaedic and trauma surgery2026
Vascular bone tumors of the pelvis and extremities: an 18-case clinical and radiological analysis.
Article in Archives of orthopaedic and trauma surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundPrimary vascular bone tumors are rare, spanning from benign to highly malignant lesions. Pelvic and extremity involvement is uncommon, and differentiation between benign and malignant tumors remains challenging due to overlapping radiological and pathological features. This study aimed to identify imaging predictors of malignancy and evaluate clinical outcomes in vascular bone tumors of the pelvis and extremities.
methodsWe retrospectively analyzed 18 patients diagnosed with vascular bone tumors between 2013 and 2024. Tumors were classified as benign (hemangioma, epithelioid hemangioma; n = 11) or malignant (angiosarcoma, epithelioid hemangioendothelioma; n = 7). Demographic, radiological (plain radiographs, MRI, CT), and clinical data were collected. Cortical expansion/destruction, pathological fractures, soft tissue components, and tumor size were assessed. Statistical analysis included Fisher's exact test, Mann-Whitney U test, Spearman correlation, and ROC analysis to identify predictors of malignancy.
resultsMedian age was 41.0 years for benign and 53.0 years for malignant tumors. Soft tissue components were significantly more frequent in malignant tumors (57% vs. 9%, p = 0.025), and tumor size was larger (mean 9.0 cm vs. 3.7 cm, p = 0.001). Cortical expansion, destruction, and pathological fractures did not differ significantly. ROC analysis suggested that larger tumor size (≥ 5.5 cm in this cohort) was associated with malignancy with 85.7% sensitivity and 90.9% specificity (AUC = 0.929, p = 0.003) and should be interpreted as an exploratory finding. All benign tumors underwent intralesional curettage, with no recurrences or complications observed. In contrast, malignant tumors exhibited high rates of relapse and mortality, with only one patient with epithelioid hemangioendothelioma surviving with stable disease at 112 months.
conclusionIn vascular bone tumors of the pelvis and extremities, the presence of a soft tissue component and tumor size ≥ 5.5 cm are among the most useful radiological features associated with malignancy. While benign lesions generally have excellent outcomes with curettage, malignant tumors are associated with a poor prognosis. Histopathological confirmation remains essential, and larger series are needed to refine diagnostic and prognostic criteria.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.